Medivation Inc (NASDAQ:MDVN) announced that for the third year in a row it was named among the top mid-sized companies in the San Francisco …
Medivation Inc (NASDAQ:MDVN) announced that it has issued a notice of redemption to redeem on July 24, 2015 all of its outstanding 2.625% Convertible …
Medivation Inc (NASDAQ:MDVN) and Astellas announced that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patie nts), a …
I generally advise investors which small cap biotech stocks are worth a look. Medivation Inc (NASDAQ:MDVN) was a small cap stock when …
Maxim Group analyst Jason Kolbert came out with a favorable report on Medivation Inc (NASDAQ:MDVN), raising the price target to $168 (from $155), …
Medivation Inc (NASDAQ:MDVN) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment …
Medivation Inc (NASDAQ:MDVN) announced the appointment of Andrew Powell as senior vice president, general counsel and corporate secretary, effective May 27, 2015. Andrew …
Medivation Inc (NASDAQ:MDVN) reported its financial results for the first quarter endedMarch 31, 2015. U.
Medivation Inc (NASDAQ:MDVN) issued a joint statement with Astellas Pharma on Monday announcing detailed results for the use of enzalutamide in castration-resistant prostate …
In a research report published Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Medivation Inc (NASDAQ:MDVN) and raised the price target to $125 (from $118), …
